FARALLON CAPITAL MANAGEMENT, L.L.C. — 13F holdings

FARALLON CAPITAL MANAGEMENT, L.L.C. reported 89 holdings worth $21.7B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. SPY SPDR S&P 500 ETF TR — $4.48B (20.7%)
2. RVMD REVOLUTION Medicines Inc — $2.54B (11.7%)
3. EA ELECTRONIC ARTS INC — $1.62B (7.5%)
4. BBIO BRIDGEBIO PHARMA INC — $800M (3.7%)
5. PTGX PROTAGONIST THERAPEUTICS INC — $778M (3.6%)
6. EXEL EXELIXIS INC — $733M (3.4%)
7. LQDA LIQUIDIA CORPORATION — $667M (3.1%)
8. AMZN AMAZON COM INC — $628M (2.9%)
9. LNTH LANTHEUS HLDGS INC — $619M (2.9%)
10. NTRA NATERA INC — $602M (2.8%)